SlideShare a Scribd company logo
1 of 33
Download to read offline
© 2007 Center for Pharmaceutical Learning
W.H.O. G.M.P. INSPECTION PERFORMA
DATE OF INSPECTING FIRM’S
REPRESENTATIVES
INSPECTION OFFICERS: PRESENT DURING
INSPECTION
FIRM’S NAME: PHONE NO. :
ADDRESS:
LICENCE NO.:
CATEGORIES OF DRUGS MANUFACTURED
AND PRODUCTION CAPACITY:
DETAILS OF EXPORT, IF UNDERTAKEN
ALREADY:
TECHNICAL PERSONNEL:
MANUFACTURING:
QUALITY CONTROL:
PRODUCTS TO BE CERTIFIED:
PRODUCTS LICENSED:
WHETHER SITEMASTER FILE SUBMITTED
IF YES, COMMENTS OF INSPECTING
OFFICER ON SITE MASTER FILE.
© 2007 Center for Pharmaceutical Learning
Complaint Yes/No Remark if non
complaint
1. PERSONNEL:
1.1 IS ORGANISATION CHART AVAILABLE:
1.2 ARE NO. OF PERSONNEL ADEQUATE:
1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY
PERSONNEL(CHECK WITH SMF):
1.4 IS QUALIFICATION AND EXPERIENCE OF
PERSONNEL COMMENSURATE WITH JOB
DESCRIPTION:
1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH
TECHNICAL PERSONNEL SPECIFIED IN WRITTING
WITH JOB DESCRIPTION:
1.6 CHECK WHETHER THERE ARE GAPS OR
UNEXPLAINED OVERLAP OF RESPONSIBILITIES
OF THE CONCERNED PERSONNEL:
2. TRAINING OF PERSONNEL:
2.1 IS WRITTEN PROGRAMME FOR TRAINING
AVAILABLE:
2.2 ARE ALL PERSONNEL TRAINED INITIALLY:
2.3 ARE PERIODICAL ASSESMENT RECORDS
AVAILABLE
2.4 IS SPECIAL PROGRAMME AVAILABLE FOR
PERSONNEL WORKING IN CLEAN AREAS AND
AREAS WHERE HIGHLY ACTIVE AND TOXIC
MATERIAL & HANDLED:
2.5 IS SOPs FOR TRAINING OF PERSONNEL
AVAILABLE:
3. PERSONNEL HYGIENE OF PERSONNEL:
3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED
PRIOR TO = AND DURING EMPLOYMENT:
3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS
DICTATE:
3.3 IS SOPs FOR CLOTHING AND HYGIENE
AVAILABLE:
© 2007 Center for Pharmaceutical Learning
3.4 ARE CLEAN UNIFORMS AND HAIR COVERING
CAPS USED:
3.5 CHECK NO. OF UNIFORMS PROVIDED. ARE
THEY ADEQUATE:
3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED
FOR VISITORS / OUTSIDE PERSONNEL
ENTERING IN PRODUCTION AREAS. ARE THEY
ADEQUATE:
4. PREMISES :
4.1 BRIEF DESCRIPTION OF BUILDING
4.2 IS DESIGNS AND CONSTRUCTED:
4.3 IS THE PREMISES COMPLY WITH SMF AND
SITUATED IN AN ENVIRONMENT WHICH CAUSED
MINIMUM RISK OF CONTAMINATION TO
MATERIALS OR PRODUCTS:
4.4 IS AREA PROVIDED COMMENSURATE WITH
PRODUCTION:
4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED
IN THE PREMISES. IF YES, GIVE DETAILS:
4.6 ARE SOPs AVAILABLE FOR MAINTENANCE,
CLEANING AND SANITATION OF BUILDINGS,
PREMISES AND SURROUNDING
4.7 CHECK WHETHER THE AREA IS CLEANED AND
VALIDATED BEFORE STARTING STORING
/PROCESING /PACKING OPERATIONS:
4.8 IS ELECTRICAL SUPPLY,
LIGHTING,TEMPERATURE,HUMIDITY,AND
VENTILATION APPROPRIATE:
4.9 ARE ARRANGEMENT MADE FOR CONTROL OF
ENTRY OF RODENTS& BIRD
4.10 ARE FOLLOWING AREAS PROVIDED:
(A) SEPARATE REST ROOMS AND REFRESHMENT
ROOMS:
(B) SEPARATE CHANGING ROOMS AND TOILETS
FOR MALE AND FEMALE WORKERS:
(C) WORKSHOP IN A SEPARATE PLACE:
(D) ANIMAL HOUSES WITH SEPARATE ENTRY AND
AIR HANDLING UNIT:
5. STORAGE AREAS:
5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE
© 2007 Center for Pharmaceutical Learning
OF MATERIALS:
5.2 INDICATE AREAS FOR EACH CATEGORY AND
WHETHER BARRIERS ARE PROVIDED IF NOT,
EXPLAIN MODE OF SEGREGATION:
RAW MATERIALS:
QUARANTINE:
APPROVED:
REJECTED:
PACKING MATERIALS:
IS ACCESS TO QUARANTINE AREA
RESTRICTED:
5.4 ARE REJECTED GOODS MARKED AND STORED
SEPARATELY IN A SECURED AREA:
5.5 ARE RECORDS FOR ACTION TAKEN ON
REJECTED GOODS AVAILABLE:
5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN
CONTROLLED TEMPERATURE/ HUMIDITY:
5.7 IS RECORD OF TEMPERATURE AND HUMIDITY
MAINTAINED:
5.8 ARE RECEIVING BAYS COVERED
5.9 ARE INCOMING MATERIALS CLEANED BEFORE
ENTRY TO STORAGE AREA:
5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF ,
NOT HOW CONTAMINATION AND CROSS
CONTAMINATION IS PREVENTED:
5.11 ARE SENSITIVE MATERIALS/
HORMONES,BLACTUM, ANTIBIOTICS,
NARCOTICS,INFLAMMABLES, EXPLOSIVES
STORED IN SECURED AREA:
5.12 ARE PRINTED/CODED PACKING MATERIALS AND
CUT LABELS STORED IN SECURED AREA WITH
RESTRICTED ENTRY,AND WHETHER PACKING
MATERIALS LINE LABELS,CARTONS.LEAFLETS
ARE IN PIGEON HOLE, ALMIRAH:
5.13 IS DISPENSING AREA PROVIDED WITH DUST
© 2007 Center for Pharmaceutical Learning
CONTROL PROVISION:
5.14 DESCRIBE THE PRIMARY PACKING MATERIALS
STORAGE AREA:
6. PRODUCTION AREA:
6.1 ARE PRODUCTION AREAS FOR THE
FOLLOWINGS SEPARATED AND SELF CONTAIN.
DESCRIBE THE NATURE OF SEPARATION:
(A) BETA- LACTUM ANTIBIOTICS:
(B) HORMONES/CORTICOSTEROIDS
(C) OTHER DRUGS.
6.2 WHETHER THE ACCESS TO PRODUCTION AREA
RESTRICTED TO AUTHORISED PERSONNEL:
6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND
FREE FROM CRACKS:
6.4 IS THE PRODUCTION AREA WELL-LIT:
6.5 HOW CROSS CONTAMINATION OF STARTING
MATERIAL OR OF A PRODUCT BY ANOTHER
MATERIAL OR PRODUCT IS PREVENTED:
6.6 IS THE LAY OUT OF MANUFACTURING DIVISION
OF EACH CATEGORY OF DOSAGE FORM IN
LOGICAL SEQUENCE. IF NOT, GIVE DETAILS
WITH REFERENCE TO FLOOR PLAN:
6.7 IS WORKING SPACE ADEQUATE AND ATLEAST
ONE METER PROVIDED AROUND FOR EACH
EQUIPMENT:
6.8 ARE SERVICE LINES, LIGHT FITTINGS
CONCEALED AND FLUSHED TO THE SURFACE
OR MADE ACCESSIBLE FROM OUTSIDE. LOOK
FOR PROTRUDING SURFACE AND SPECIFY:
6.9 ARE DRAINE PROVIDED WITH TRAPS TO AVOID
BACK FLOW
6.10 ARE DRAINS CLEANED AND DISINFECTED
PERIODICALLY. CHECK RECORDS:
6.11 IS PRODUCTION AREA PROVIDED WITH PROPER
VENTILATION WITH AIRCONTROL FACILITIES
(FILTRATION, TEMPERATURE AND
HUMIDITY).ARE RECORDS MAINTAINED
© 2007 Center for Pharmaceutical Learning
THEREOF.
6.12 ARE LOCKERS PROVIDED FOR STORAGE OF
TOOLS AND PARTS:
6.13 ARE PACKAGING AND VISUAL INSPECTION
AREAS DESIGNED TO FACILITATE SEGREGATION
FOR EACH WORK LINE:
6.14 ARE EQUIPMENTS:
(A) LOCATED IN LOGICAL SEQUENCE (GIVE
BRIEF DESCRIPTION):
(B) DESIGNED, CONSTRUCTED TO SUIT THE
PURPOSE:
(C) PERMIT EFFECTIVE CLEANING:
(D) CLEANED BETWEEN BATCH OPERATION
AND RECORDED.CHECK RECORDS:
(E) CALLED TO INDICATE THEIR STATUS:
6.15 ARE SERVICE LINES PAINTED TO INDICATE THE
CONTENTS AND FLOW. RECORDS THE ORDER
SCHEME:
6.16 ARE BALANCES AND MEASURING EQUIPMENTS
CALIBRATED PERIODICALLY.CHECK RECORDS
AND PERIODICITY:
6.17 ARE WEIGHING EQUIPMENTS AND MEASURING
EQUIPMENTS OF APPROPRIATE RANGE AND
PRECISION AVAILABLE. CHECK CAPACITY OF
THE EQUIPMENT VIS-À-VIS BATCH SIZES OF
PRODUCTION:
6.18 CHECK THE TYPE OF WASHING AND CLEANING
EQUIPMENTS IN PRODUCTION AREA.(PARTICLE
GENERATING EQUIPMENTS SHOULD NOT BE
USED):
6.19 HOW DEFECTIVE EQUIPMENTS ARE
SEGREGATED:
7. MATERIALS:
7.1 IS SEGREGATION IS LOTWISE AND STOCK
ROTATION BY FIFO ADOPTED:
7.2 DOES PURCHASE DEPARTMENT STAFF
KNOWLEDGEABLE ABOUT THE PRODUCTS AND
MATERIALS:
7.3 HOW SUPPLIERS ARE SELECTED:
7.4 ARE SUPPLIERS EVALUATED AND APPROVED
AND THEIR NAME INCLUDED IN SPECIFICATION:
© 2007 Center for Pharmaceutical Learning
7.5 ARE PURCHASES MADE DIRECTLY FROM
PRODUCERS:
7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND
CONFORMITY WITH ORDER ON RECEIPT:
7.7 IS DAMAGE RECORDED AND REPORTED TO
QUALITY CONTROL:
7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. ,
STATUS,EXPIRY DATE , RETEST DATE
ETC.(COLLECT) SAMPLE OF INHOUSE LABELS):
7.9 IS COLOUR CODING SYSTEM USED TO INDICATE
STATUS:
7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND
RELEASED:
7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND
DISPENSING AVAILABLE. COMPARE SOPs WITH
ACTUAL PRACTICE:
7.12 IS SAMPLING AND DISPENSING DONE BY
DESIGNATED PERSONS:
7.13 IS EACH DISPENSING CHECKED AND
RECORDED.
7.14 IS ADEQUATE STORAGE AREA FOR FINISHED
GOODS PROVIDED:
7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED
PRODUCTS PROVIDED:
7.16 ARE PACKING MATERIALS CHECKED ON
DELIVERY AND ASSIGNED A SPECIFIC
REFERENCE NUMBER:
7.17 HOW THE WASTE MATERIALS FROM
STORE,PRODUCTION, QUALITYCONTROL
DISPOSED OFF:
7.18 IS THERE ACCUMULATION OF WASTE MATERIAL
AT ANY PART OF THE STORAGE/
PRODUCTION/Q.C.AREA:
8. DOCUMENTATION:
8.1 ARE ALL DOCUMENTS PREPARED AND
REVIEWED BY COMPETENT PERSONNEL
APPROVED AND SIGNED BY AUTHORISED
PERSONNEL:
8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED:
8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR
EASY FOR REPRODUCTION AND EASY TO
CHECK:
© 2007 Center for Pharmaceutical Learning
8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF
YES, ARE ALTERATIONS CLEAR, LEGIBLE AND
INITIALLED(OVER WRITING IS NOT PERMITTED):
8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE
WITH NECESSARY DETAILS:
(A) TESTING PROCEDURES FOR STARTING
MATERIALS, INTERMEDIATE PRODUCTS
AND FINISHED PRODUCTS,PACKING
MATERIALS:
(B) VALIDATION OF TESTING PROCEDURE:
(C) MASTER FORMULA CARD(COLLECT
SPECIMEN):
(D) PACKAGING INSTRUCTION (COLLECT
SPECIMEN):
(E) BATCH PROCESSING CARDS INCLUDING
INPROCESS CONTROLS.(COLLECT
SPECIMEN):
(F) BATCH PACKAGING CARD (COLLECT
SPECIMEN):
(G) REFERENCE STANDARDS:
(H) DISPOSAL RECORD OF OUTDATED
PRIMARY AND PRINTED PACKING
MATERIALS:
(I) RELEASE RECORDS:
(J) DISTRIBUTION RECORDS.(WITH WHAT
LEVEL):
(K) COMPARE MASTER FORMULA CARD WITH
© 2007 Center for Pharmaceutical Learning
ACTUAL PRACTICE:
8.6 ARE ALL RECORDS AND ASSOCIATED SOPs
RETAINED UPTO ONE YEAR AFTER EXPIRY OF
FINISHED PRODUCT:
8.7 ARE STANDARD OPERATING PROCEDURES FOR
THE FOLLOWING OPERATIONS AVAILABLE:
(A) RECEIPT MATERIALS:
(B) ENVIRONMENTAL MONITORING:
(C) INTERNAL LABELLING , QUARANTINE AND
STORAGE OF MATERIALS:
(D) EACH INSTRUMENT AND EQUIPMENT IN
THEIR PREXIMITY:
(E) EQUIPMENT ASSEMBLY AND VALIDATION:
(F) SAMPLING(RAW MATERIALS AND FINISHED
PRODUCTS):
(G) DISPENSING (RAW MATERIALS AND
PACKING MATERIALS):
(H) BATCH NUMBERING SYSTEM:
(I) RELEASE OR REJECTION:
(J) LOG BOOK FOR EACH EQUOPMENT AND
INSTRUMENT:
(K) SANITATION AND CLEANING OF PREMISES
AND EQUIPMENT:
(L) SANITATION OF PIPES CARRYING
DISTILLED/DEIONISED WATER:
© 2007 Center for Pharmaceutical Learning
(M)RECOVERY FROM REJECTED PRODUCTS:
(N) DISPOSAL/REUSE OF RETURNED GOODS:
(O) PEST CONTROL:
(P) ANALYTICAL APPARATUS AND
CALIBRATION:
(Q) COMPLAINTS,RECALLS AND RETURNS:
(R) COMPARE SOPs WITH ACTUAL PRACTICE:
9. PRODUCTION:
9.1 IS THERE ANY DEVIATION FROM SOPs
MANUFACTURING PROCEDURES:
9.2 IS YIELD CHECKED AT EACH STAGE:
9.3 IS MORE THAN ONE PRODUCT PROCESSED IN
THE SAME ROOM:
9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO
INDICATE THE OPERATION IN PROGRESS:
9.5 IS ANY NON MEDICAL PRODUCT PRODUCED.
SPECIFY THE DETAILS:
9.6 IS THERE PROVISION FOR INPROCESS
CONTROLS IN THE PRODUCTION AREA(MUST
NOT EFFECT THE QUALITY OF THE PRIODUCTS
MANUFACTURED):
9.7 IS THERE PROVISION FOR DUST COLLECTION
WHERE DRY MATERIALS ARE HANDLED:
9.8 IS PERIODICAL MICROBIAL MONITORING OF
PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS
CONDUCTED:
9.9 WAS THE AREA BEING CLEANED BEFORE
STARTING EVERY BATCH:
9.10 ARE PIPES CARRYING DISTILLED/DEIONISED
WATER SANITIZED ACCORDING TO PROCEDURE
WHICH INDICATE LIMITS FOR MICROBIAL
CONTAMINATION AND MEASURES TO BE TAKEN:
9.11 WAS ANY BATCH REPROCESSED FROM
© 2007 Center for Pharmaceutical Learning
REJECTED PRODUCTS:
9.12 WAS ANY BATCH RETURNED HAS BEEN
CONVERTED FOR RESALE , RELABELLING OR
BULKING:
10. PACKAGING:
10.1 IS THERE ADEQUATE SEPARATION OF PACKING
LINES TO PREVENT ANY MIX-UP:
10.2 IS EACH PACKAGING LINE IDENTIFIED WITH
PRODUCT NAME, BATCH NO. AND PACKAGING
SIZE:
10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING
SIZE ON A LINE AT ANY GIVEN TIME:
10.4 IS LINE CLEARED BEFORE EACH BATCH
OPERATION,CERTIFIED AND RECORDED:
10.5 DOES PACKING QUICKLY FOLLOWS THE FILLING
AND SEALING:
10.6 ARE ALL CODED PACKING MATERIALS VERIFIED
BEFORE USE.
10.7 IS RECONCILATION OF PACKING MATERIALS
USED VIS-À-VIS PRODUCT RECORDED:
10.8 IS ON LINE COTROL PROCEDURE DURING
PACKING AVAILABLE:
11. QUALITY CONTROL:
11.1 HOW FAR THE HEAD OF QUALITY CONTROL
AND PRODUCTION ARE INDEPENDENT OF EACH
OTHER:
11.2 ARE ALL THE PROCEDURES OF
DOCUMEBNTED:
11.3 IS SAMPLING PROCEDURE ADEQUATE:
11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW
BATCH NO. , NAME,CONTAINER NO., DATE OF
SAMPLING AND PERSON WHO SAMPLED:
11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER
OF STARTING MATERIALS:
11.6 ARE ANALYTICAL RECORDS OF EACH BATCH
OF THE RAW MATERIALS,INTERMEDIATES AND
FINISHED PRODUCTS AVAILABLE WITH WORK
SHEETS:
11.7 ARE PRODUCTION RECORDS REVIEWED:
11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE
YEAR AFTER EXPIRY DATE AND OTHER
© 2007 Center for Pharmaceutical Learning
STARTING MATERIALS FOR A MINIMUM OF TWO
YEARS:
11.9 IS PROGRAMME FOR STABILITY TESTING OF
STARTING MATERIALS AND FINISHED
PRODUCTS AVAILABLE:
11.10 IS STABILITY TESTING CONDUCTED PRIOR TO
MARKETING AND AFTER CHANGE OF PROCESS
EQUIPMENT,PACKING MATERIALS:
11.11 IS QUALITY CONTROL LAB SEPARATE FROM
PRODUCTION AREA:
11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL
TESTING AREAS SEPARATE FROM EACH
OTHER,AND DO THEY HAVE SEPARATE AIR
HANDLING FACILITIES:
11.13 IS INSTRUMENT ROOM SEPARATE:
11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE
SPACE,VENTILATION AND FOR PREVENTION OF
FUMES:
11.15 ARE RECORDS OF SERVICE AND CALIBRATION
OF INSTRUMENT AVAILABLE:
11.16 ARE APPROPRIATE SAMPLING EQUIPMENT
AVAILABLE AND STARTED SEPARATELY:
11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR
TO USE:
11.18 ARE DATE OF CALIBRATION , SERVICE ,AND
DATE WHEN RECALIBRATION DUE INDICATED:
11.19 ARE THE REAGENTS PREPARED ACCORDING
TO WRITTEN PROCEDURES AND LABELLED
APPROPRIATELY:
11.20 ARE REFERENCE STANDARDS AVAILABLE
CORRESPOND TO THE MATERIALS ANALYSED:
11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY
WITH COOLING) AND RECORDS ARE AVAILABLE
FOR REFERENCE STANDARDS AND
REFERENCE SAMPLES. CHECK THE MODE OF
STORAGE OF REFERENCE STANDARDS:
11.22 ARE WORKING STANDARDS CHECKED AT
REGULAR INTERVALS:
11.23 ARE THE LABELS OF REF. STANDARDS
INDICATE NAME, DATE OF MFG. DATE OF
EXPIRY,CONCENTRATION AND DATE OF
CLOSURE IS FIRST OPENED AND STORAGE
CONDITIONS:
© 2007 Center for Pharmaceutical Learning
11.24 ARE THE LABEL OF REAGENTS PREPARED
SHOW CONCENTRATION , STANDARDISATION
FACTOR, SELF- LIFE,STANDARDISATION DATE
,STORAGE CONDITION AND SIGNATURE OF THE
PERSON PREPARES THE REAGENTS:
11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED
TO TEST SUITABILITY OF CULTURE MEDIA:
11.26 ARE STABILITY STUDIES CONDUCTED BEFORE
ASSIGNING SHELF LIFE AND IS IT PERIODICALL
REVIEWED, AND GIVE DETAILS:
12. SELF INSPECTION:
GIVE DETAILS OF NAMES,
QUALIFICATION AND BACKGROUND
OF THE MEMBERS OF SELF
INSPECTION TEAM:
12.1 INTERVAL PERIOD BETWEEN SELF
INSPECTIONS:
12.2 DOES SELF INSPECTION REPORT CONTAINS
COMMENTS ON:
(A) PERSONNEL:
(B) PREMISES:
(C) MAINTENANCE OF BUILDING AND
EQUIPMENT:
(D) STORAGE:
(E) EQUIPMENT:
(F) PRODUCTION AND INPROCESS
CONTROL:
(G)QUALITY CONTROL:
(H) DOCUMENTATION:
© 2007 Center for Pharmaceutical Learning
(I) SANITATION AND HYGIENE:
(J) VALIDATION PROCEDURE /
PROGRAMMES:
(K) CALIBRATION OF INSTRUMENTS:
(L) RECALL PROCEDURES:
(M)LABELS CONTROL:
(N) COMPLAINTS:
(O)CORRECTIVE ACTION ON PREVIOUS
REPORTS:
13 RECALL PROCEDURE :
EXPLAIN PROCEDURE ADOPTED FOR RECALL
OF PRODUCTS:
14 QUALITY AUDIT SYSTEM :
(BRIEF RESPONSIBILITIES
REMARKS:
1.1 IS ORGANISATION CHART
AVAILABLE:
1.2 ARE NO. OF PERSONNEL
ADEQUATE:
1.3 NAME ,QUALIFICATION AND
EXPERIENCE OF KEY
PERSONNEL(CHECK WITH SMF):
1.4 IS QUALIFICATION AND
EXPERIENCE OF PERSONNEL
COMMENSURATE WITH JOB
DESCRIPTION:
1.5 IS MANAGERIAL
RESPONCIBILITIES OF EACH
© 2007 Center for Pharmaceutical Learning
TECHNICAL PERSONNEL
SPECIFIED IN WRITTING WITH
JOB DESCRIPTION:
1.6 CHECK WHETHER THERE ARE
GAPS OR UNEXPLAINED
OVERLAP OF RESPONSIBILITIES
OF THE CONCERNED
PERSONNEL:
2. TRAINING OF PERSONNEL:
2.1 IS WRITTEN PROGRAMME FOR
TRAINING AVAILABLE:
2.2 ARE ALL PERSONNEL TRAINED
INITIALLY:
2.3 ARE PERIODICAL ASSESMENT
RECORDS AVAILABLE
2.4 IS SPECIAL PROGRAMME
AVAILABLE FOR PERSONNEL
WORKING IN CLEAN AREAS
AND AREAS WHERE HIGHLY
ACTIVE AND TOXIC MATERIAL
& HANDLED:
2.5 IS SOPs FOR TRAINING OF
PERSONNEL AVAILABLE:
3. PERSONNEL HYGIENE OF PERSONNEL:
3.1 ARE ALL PERSONNEL
MEDICALLY EXAMINED PRIOR TO
= AND DURING EMPLOYMENT:
3.2 ARE THEY RESTRICTED , IF
MEDICAL REASONS DICTATE:
3.3 IS SOPs FOR CLOTHING AND
HYGIENE AVAILABLE:
3.4 ARE CLEAN UNIFORMS AND HAIR
COVERING CAPS USED:
3.5 CHECK NO. OF UNIFORMS
© 2007 Center for Pharmaceutical Learning
PROVIDED. ARE THEY
ADEQUATE:
3.6 WHAT PROTECTIVE CLOTHING
ARE PROVIDED FOR VISITORS /
OUTSIDE PERSONNEL ENTERING
IN PRODUCTION AREAS. ARE
THEY ADEQUATE:
6. PREMISES :
4.1 BRIEF DESCRIPTION OF BUILDING
4.2 IS DESIGNS AND CONSTRUCTED:
4.3 IS THE PREMISES COMPLY WITH SMF
AND SITUATED IN AN ENVIRONMENT
WHICH CAUSED MINIMUM RISK OF
CONTAMINATION TO MATERIALS OR
PRODUCTS:
4.4 IS AREA PROVIDED COMMENSURATE
WITH PRODUCTION:
4.5 ARE NON MEDICAL PRODUCTS
MANUFACTURED IN THE PREMISES. IF
YES, GIVE DETAILS:
4.6 ARE SOPs AVAILABLE FOR
MAINTENANCE, CLEANING AND
SANITATION OF BUILDINGS, PREMISES
AND SURROUNDING
4.7 CHECK WHETHER THE AREA IS CLEANED
AND VALIDATED BEFORE STARTING
STORING /PROCESING /PACKING
OPERATIONS:
4.8 IS ELECTRICAL SUPPLY,
LIGHTING,TEMPERATURE,HUMIDITY,AND
VENTILATION APPROPRIATE:
4.9 ARE ARRANGEMENT MADE FOR
CONTROL OF ENTRY OF RODENTS& BIRD
4.10 ARE FOLLOWING AREAS PROVIDED:
(A) SEPARATE REST ROOMS AND
REFRESHMENT ROOMS:
(B) SEPARATE CHANGING ROOMS
AND TOILETS FOR MALE AND
© 2007 Center for Pharmaceutical Learning
FEMALE WORKERS:
(C) WORKSHOP IN A SEPARATE
PLACE:
(D) ANIMAL HOUSES WITH
SEPARATE ENTRY AND AIR
HANDLING UNIT:
7. STORAGE AREAS:
5.1 IS AREA SUFFICIENT FOR
ORDERLY STORAGE OF
MATERIALS:
5.2 INDICATE AREAS FOR EACH
CATEGORY AND WHETHER
BARRIERS ARE PROVIDED IF
NOT, EXPLAIN MODE OF
SEGREGATION:
RAW MATERIALS:
QUARANTINE:
APPROVED:
REJECTED:
PACKING MATERIALS:
IS ACCESS TO QUARANTINE
AREA RESTRICTED:
5.4 ARE REJECTED GOODS
MARKED AND STORED
SEPARATELY IN A SECURED
AREA:
5.5 ARE RECORDS FOR ACTION
TAKEN ON REJECTED GOODS
AVAILABLE:
5.6 ARE FACILITIES AVAILABLE
FOR STORAGE IN
© 2007 Center for Pharmaceutical Learning
CONTROLLED TEMPERATURE/
HUMIDITY:
5.7 IS RECORD OF TEMPERATURE
AND HUMIDITY MAINTAINED:
5.8 ARE RECEIVING BAYS
COVERED
5.9 ARE INCOMING MATERIALS
CLEANED BEFORE ENTRY TO
STORAGE AREA:
5.10 IS SEPARATE SAMPLING AREA
PROVIDED.IF , NOT HOW
CONTAMINATION AND CROSS
CONTAMINATION IS
PREVENTED:
5.11 ARE SENSITIVE MATERIALS/
HORMONES,BLACTUM,
ANTIBIOTICS,
NARCOTICS,INFLAMMABLES,
EXPLOSIVES STORED IN
SECURED AREA:
5.12 ARE PRINTED/CODED
PACKING MATERIALS AND
CUT LABELS STORED IN
SECURED AREA WITH
RESTRICTED ENTRY,AND
WHETHER PACKING
MATERIALS LINE
LABELS,CARTONS.LEAFLETS
ARE IN PIGEON HOLE,
ALMIRAH:
5.13 IS DISPENSING AREA
PROVIDED WITH DUST
CONTROL PROVISION:
5.14 DESCRIBE THE PRIMARY
PACKING MATERIALS
STORAGE AREA:
7. PRODUCTION AREA:
© 2007 Center for Pharmaceutical Learning
6.1 ARE PRODUCTION AREAS FOR THE
FOLLOWINGS SEPARATED AND SELF
CONTAIN. DESCRIBE THE NATURE OF
SEPARATION:
(D) BETA- LACTUM ANTIBIOTICS:
(E) HORMONES/CORTICOSTEROIDS
(F) OTHER DRUGS.
6.2 WHETHER THE ACCESS TO
PRODUCTION AREA RESTRICTED TO
AUTHORISED PERSONNEL:
6.3 ARE WALLS, FLOORS AND CEILING
SMOOTH AND FREE FROM CRACKS:
6.4 IS THE PRODUCTION AREA WELL-LIT:
6.5 HOW CROSS CONTAMINATION
OF STARTING MATERIAL OR
OF A PRODUCT BY ANOTHER
MATERIAL OR PRODUCT IS
PREVENTED:
6.6 IS THE LAY OUT OF
MANUFACTURING DIVISION
OF EACH CATEGORY OF
DOSAGE FORM IN LOGICAL
SEQUENCE. IF NOT, GIVE
DETAILS WITH REFERENCE TO
FLOOR PLAN:
6.7 IS WORKING SPACE
ADEQUATE AND ATLEAST
ONE METER PROVIDED
AROUND FOR EACH
EQUIPMENT:
6.8 ARE SERVICE LINES, LIGHT
FITTINGS CONCEALED AND
FLUSHED TO THE SURFACE OR
MADE ACCESSIBLE FROM
OUTSIDE. LOOK FOR
PROTRUDING SURFACE AND
SPECIFY:
6.9 ARE DRAINE PROVIDED WITH
© 2007 Center for Pharmaceutical Learning
TRAPS TO AVOID BACK FLOW
6.10 ARE DRAINS CLEANED AND
DISINFECTED PERIODICALLY.
CHECK RECORDS:
6.11 IS PRODUCTION AREA
PROVIDED WITH PROPER
VENTILATION WITH
AIRCONTROL FACILITIES
(FILTRATION, TEMPERATURE
AND HUMIDITY).ARE
RECORDS MAINTAINED
THEREOF.
6.12 ARE LOCKERS PROVIDED FOR
STORAGE OF TOOLS AND
PARTS:
6.13 ARE PACKAGING AND VISUAL
INSPECTION AREAS DESIGNED
TO FACILITATE SEGREGATION
FOR EACH WORK LINE:
6.14 ARE EQUIPMENTS:
(F) LOCATED IN LOGICAL
SEQUENCE (GIVE BRIEF
DESCRIPTION):
(G) DESIGNED,
CONSTRUCTED TO SUIT
THE PURPOSE:
(H) PERMIT EFFECTIVE
CLEANING:
(I) CLEANED BETWEEN
BATCH OPERATION AND
RECORDED.CHECK
RECORDS:
(J) CALLED TO INDICATE
THEIR STATUS:
6.15 ARE SERVICE LINES PAINTED
TO INDICATE THE CONTENTS
AND FLOW. RECORDS THE
ORDER SCHEME:
6.16 ARE BALANCES AND
© 2007 Center for Pharmaceutical Learning
MEASURING EQUIPMENTS
CALIBRATED
PERIODICALLY.CHECK
RECORDS AND PERIODICITY:
6.17 ARE WEIGHING EQUIPMENTS
AND MEASURING
EQUIPMENTS OF APPROPRIATE
RANGE AND PRECISION
AVAILABLE. CHECK
CAPACITY OF THE EQUIPMENT
VIS-À-VIS BATCH SIZES OF
PRODUCTION:
6.18 CHECK THE TYPE OF WASHING
AND CLEANING EQUIPMENTS
IN PRODUCTION
AREA.(PARTICLE GENERATING
EQUIPMENTS SHOULD NOT BE
USED):
6.19 HOW DEFECTIVE EQUIPMENTS
ARE SEGREGATED:
8. MATERIALS:
7.1 IS SEGREGATION IS LOTWISE
AND STOCK ROTATION BY
FIFO ADOPTED:
7.2 DOES PURCHASE
DEPARTMENT STAFF
KNOWLEDGEABLE ABOUT
THE PRODUCTS AND
MATERIALS:
7.3 HOW SUPPLIERS ARE
SELECTED:
7.4 ARE SUPPLIERS EVALUATED
AND APPROVED AND THEIR
NAME INCLUDED IN
SPECIFICATION:
7.5 ARE PURCHASES MADE
DIRECTLY FROM PRODUCERS:
7.6 ARE MATERIALS CHECKED
FOR INTEGRITY AND
CONFORMITY WITH ORDER ON
RECEIPT:
© 2007 Center for Pharmaceutical Learning
7.7 IS DAMAGE RECORDED AND
REPORTED TO QUALITY
CONTROL:
7.8 DO THE LABELS SHOW B.NO,
NAME, C.R.NO. ,
STATUS,EXPIRY DATE ,
RETEST DATE ETC.(COLLECT)
SAMPLE OF INHOUSE LABELS):
7.9 IS COLOUR CODING SYSTEM
USED TO INDICATE STATUS:
7.10 ARE SAMPLE CONTAINERS
IDENTIFIED AND RELEASED:
7.11 ARE WRITTEN PRODUCERS
FOR SAMPLING AND
DISPENSING AVAILABLE.
COMPARE SOPs WITH ACTUAL
PRACTICE:
7.12 IS SAMPLING AND DISPENSING
DONE BY DESIGNATED
PERSONS:
7.13 IS EACH DISPENSING
CHECKED AND RECORDED.
7.14 IS ADEQUATE STORAGE AREA
FOR FINISHED GOODS
PROVIDED:
7.15 IS ADEQUATE AREA FOR
RECALLED/RETURNED
PRODUCTS PROVIDED:
7.16 ARE PACKING MATERIALS
CHECKED ON DELIVERY AND
ASSIGNED A SPECIFIC
REFERENCE NUMBER:
7.17 HOW THE WASTE MATERIALS
FROM STORE,PRODUCTION,
QUALITYCONTROL DISPOSED
OFF:
7.18 IS THERE ACCUMULATION OF
WASTE MATERIAL AT ANY
PART OF THE STORAGE/
PRODUCTION/Q.C.AREA:
© 2007 Center for Pharmaceutical Learning
9. DOCUMENTATION:
8.1 ARE ALL DOCUMENTS
PREPARED AND REVIEWED BY
COMPETENT PERSONNEL
APPROVED AND SIGNED BY
AUTHORISED PERSONNEL:
8.2 ARE ALL DOCUMENTS
PERIODICALLY REVISED:
8.3 ARE THE DOCUMENTS
UNAMBIGUOUS CLEAR EASY
FOR REPRODUCTION AND
EASY TO CHECK:
8.4 IS THERE ANY ALTERATIONS,
IN ENTRY MADE. IF YES, ARE
ALTERATIONS CLEAR,
LEGIBLE AND
INITIALLED(OVER WRITING IS
NOT PERMITTED):
8.5 ARE THE FOLLOWING
DOCUMENTS AVAILABLE WITH
NECESSARY DETAILS:
(L) TESTING PROCEDURES
FOR STARTING
MATERIALS,
INTERMEDIATE PRODUCTS
AND FINISHED
PRODUCTS,PACKING
MATERIALS:
(M)VALIDATION OF TESTING
PROCEDURE:
(N) MASTER FORMULA
CARD(COLLECT
SPECIMEN):
(O) PACKAGING INSTRUCTION
(COLLECT SPECIMEN):
© 2007 Center for Pharmaceutical Learning
(P) BATCH PROCESSING
CARDS INCLUDING
INPROCESS
CONTROLS.(COLLECT
SPECIMEN):
(Q) BATCH PACKAGING CARD
(COLLECT SPECIMEN):
(R) REFERENCE STANDARDS:
(S) DISPOSAL RECORD OF
OUTDATED PRIMARY AND
PRINTED PACKING
MATERIALS:
(T) RELEASE RECORDS:
(U) DISTRIBUTION
RECORDS.(WITH WHAT
LEVEL):
(V) COMPARE MASTER
FORMULA CARD WITH
ACTUAL PRACTICE:
8.6 ARE ALL RECORDS AND
ASSOCIATED SOPs RETAINED
UPTO ONE YEAR AFTER EXPIRY
OF FINISHED PRODUCT:
8.7 ARE STANDARD OPERATING
PROCEDURES FOR THE
FOLLOWING OPERATIONS
AVAILABLE:
(S) RECEIPT MATERIALS:
(T) ENVIRONMENTAL
MONITORING:
© 2007 Center for Pharmaceutical Learning
(U) INTERNAL LABELLING ,
QUARANTINE AND
STORAGE OF MATERIALS:
(V) EACH INSTRUMENT AND
EQUIPMENT IN THEIR
PREXIMITY:
(W)EQUIPMENT ASSEMBLY
AND VALIDATION:
(X) SAMPLING(RAW
MATERIALS AND FINISHED
PRODUCTS):
(Y) DISPENSING (RAW
MATERIALS AND PACKING
MATERIALS):
(Z) BATCH NUMBERING
SYSTEM:
(AA)RELEASE OR REJECTION:
(BB)LOG BOOK FOR EACH
EQUOPMENT AND
INSTRUMENT:
(CC)SANITATION AND
CLEANING OF PREMISES
AND EQUIPMENT:
(DD)SANITATION OF PIPES
CARRYING
DISTILLED/DEIONISED
WATER:
© 2007 Center for Pharmaceutical Learning
(EE)RECOVERY FROM
REJECTED PRODUCTS:
(FF)DISPOSAL/REUSE OF
RETURNED GOODS:
(GG)PEST CONTROL:
(HH)ANALYTICAL APPARATUS
AND CALIBRATION:
(II) COMPLAINTS,RECALLS
AND RETURNS:
(JJ) COMPARE SOPs WITH
ACTUAL PRACTICE:
11. PRODUCTION:
9.1 IS THERE ANY DEVIATION
FROM SOPs MANUFACTURING
PROCEDURES:
9.2 IS YIELD CHECKED AT EACH
STAGE:
9.3 IS MORE THAN ONE PRODUCT
PROCESSED IN THE SAME
ROOM:
9.4 ARE EQUIPMENTS AND ROOMS
LABELLED TO INDICATE THE
OPERATION IN PROGRESS:
9.5 IS ANY NON MEDICAL
PRODUCT PRODUCED. SPECIFY
THE DETAILS:
9.6 IS THERE PROVISION FOR
INPROCESS CONTROLS IN THE
PRODUCTION AREA(MUST NOT
EFFECT THE QUALITY OF THE
PRIODUCTS MANUFACTURED):
9.7 IS THERE PROVISION FOR
© 2007 Center for Pharmaceutical Learning
DUST COLLECTION WHERE
DRY MATERIALS ARE
HANDLED:
9.8 IS PERIODICAL MICROBIAL
MONITORING OF PRODUCTION
AREAS OF SUCEPTIBLE
PRODUCTS CONDUCTED:
9.9 WAS THE AREA BEING
CLEANED BEFORE STARTING
EVERY BATCH:
9.10 ARE PIPES CARRYING
DISTILLED/DEIONISED WATER
SANITIZED ACCORDING TO
PROCEDURE WHICH INDICATE
LIMITS FOR MICROBIAL
CONTAMINATION AND
MEASURES TO BE TAKEN:
9.11 WAS ANY BATCH
REPROCESSED FROM
REJECTED PRODUCTS:
9.12 WAS ANY BATCH RETURNED
HAS BEEN CONVERTED FOR
RESALE , RELABELLING OR
BULKING:
12. PACKAGING:
10.1 IS THERE ADEQUATE
SEPARATION OF PACKING
LINES TO PREVENT ANY MIX-
UP:
10.2 IS EACH PACKAGING LINE
IDENTIFIED WITH PRODUCT
NAME, BATCH NO. AND
PACKAGING SIZE:
10.3 IS ONLY ONE PRODUCT,
BATCH AND PACKAGING SIZE
ON A LINE AT ANY GIVEN
TIME:
10.4 IS LINE CLEARED BEFORE
EACH BATCH
OPERATION,CERTIFIED AND
RECORDED:
10.5 DOES PACKING QUICKLY
© 2007 Center for Pharmaceutical Learning
FOLLOWS THE FILLING AND
SEALING:
10.6 ARE ALL CODED PACKING
MATERIALS VERIFIED BEFORE
USE.
10.7 IS RECONCILATION OF
PACKING MATERIALS USED
VIS-À-VIS PRODUCT
RECORDED:
10.8 IS ON LINE COTROL
PROCEDURE DURING PACKING
AVAILABLE:
13. QUALITY CONTROL:
11.1 HOW FAR THE HEAD OF
QUALITY CONTROL AND
PRODUCTION ARE
INDEPENDENT OF EACH OTHER:
11.2 ARE ALL THE PROCEDURES OF
DOCUMEBNTED:
11.3 IS SAMPLING PROCEDURE
ADEQUATE:
11.4 DO THE LABEL ON SAMPLE
CONTAINER, SHOW BATCH NO. ,
NAME,CONTAINER NO., DATE
OF SAMPLING AND PERSON
WHO SAMPLED:
11.5 IS IDENTIFY TEST DONE ON
EACH CONTAINER OF STARTING
MATERIALS:
11.6 ARE ANALYTICAL RECORDS OF
EACH BATCH OF THE RAW
MATERIALS,INTERMEDIATES
AND FINISHED PRODUCTS
AVAILABLE WITH WORK
SHEETS:
11.7 ARE PRODUCTION RECORDS
REVIEWED:
11.8 ARE ALL RETENTION SAMPLES
KEPT FOR ONE YEAR AFTER
EXPIRY DATE AND OTHER
© 2007 Center for Pharmaceutical Learning
STARTING MATERIALS FOR A
MINIMUM OF TWO YEARS:
11.9 IS PROGRAMME FOR STABILITY
TESTING OF STARTING
MATERIALS AND FINISHED
PRODUCTS AVAILABLE:
11.10 IS STABILITY TESTING
CONDUCTED PRIOR TO
MARKETING AND AFTER
CHANGE OF PROCESS
EQUIPMENT,PACKING
MATERIALS:
11.11 IS QUALITY CONTROL LAB
SEPARATE FROM PRODUCTION
AREA:
11.12 ARE BIOLOGICAL AND
MICROBIOLOGICAL TESTING
AREAS SEPARATE FROM EACH
OTHER,AND DO THEY HAVE
SEPARATE AIR HANDLING
FACILITIES:
11.13 IS INSTRUMENT ROOM
SEPARATE:
11.14 IS DESIGN OF LAB SUITABLE
WITH ADEQUATE
SPACE,VENTILATION AND FOR
PREVENTION OF FUMES:
11.15 ARE RECORDS OF SERVICE AND
CALIBRATION OF INSTRUMENT
AVAILABLE:
11.16 ARE APPROPRIATE SAMPLING
EQUIPMENT AVAILABLE AND
STARTED SEPARATELY:
11.17 ARE INSTRUMENTS CHECKED
DAILY OR PRIOR TO USE:
11.18 ARE DATE OF CALIBRATION ,
SERVICE ,AND DATE WHEN
RECALIBRATION DUE
INDICATED:
11.19 ARE THE REAGENTS PREPARED
ACCORDING TO WRITTEN
PROCEDURES AND LABELLED
APPROPRIATELY:
© 2007 Center for Pharmaceutical Learning
11.20 ARE REFERENCE STANDARDS
AVAILABLE CORRESPOND TO
THE MATERIALS ANALYSED:
11.21 IS ADEQUATE STORAGE SPACE
(IF NECESSARY WITH COOLING)
AND RECORDS ARE AVAILABLE
FOR REFERENCE STANDARDS
AND REFERENCE SAMPLES.
CHECK THE MODE OF STORAGE
OF REFERENCE STANDARDS:
11.22 ARE WORKING STANDARDS
CHECKED AT REGULAR
INTERVALS:
11.23 ARE THE LABELS OF REF.
STANDARDS INDICATE NAME,
DATE OF MFG. DATE OF
EXPIRY,CONCENTRATION AND
DATE OF CLOSURE IS FIRST
OPENED AND STORAGE
CONDITIONS:
11.24 ARE THE LABEL OF REAGENTS
PREPARED SHOW
CONCENTRATION ,
STANDARDISATION FACTOR,
SELF- LIFE,STANDARDISATION
DATE ,STORAGE CONDITION
AND SIGNATURE OF THE
PERSON PREPARES THE
REAGENTS:
11.25 ARE POSITIVE AND NEGATIVE
CONTROLS USED TO TEST
SUITABILITY OF CULTURE
MEDIA:
11.26 ARE STABILITY STUDIES
CONDUCTED BEFORE
ASSIGNING SHELF LIFE AND IS
IT PERIODICALL REVIEWED,
AND GIVE DETAILS:
14. SELF INSPECTION:
© 2007 Center for Pharmaceutical Learning
GIVE DETAILS OF NAMES,
QUALIFICATION AND BACKGROUND
OF THE MEMBERS OF SELF
INSPECTION TEAM:
12.1 INTERVAL PERIOD BETWEEN
SELF INSPECTIONS:
12.2 DOES SELF INSPECTION REPORT
CONTAINS COMMENTS ON:
(P) PERSONNEL:
(Q) PREMISES:
(R) MAINTENANCE OF
BUILDING AND
EQUIPMENT:
(S) STORAGE:
(T) EQUIPMENT:
(U) PRODUCTION AND
INPROCESS CONTROL:
(V) QUALITY CONTROL:
(W)DOCUMENTATION:
(X) SANITATION AND
HYGIENE:
(Y) VALIDATION PROCEDURE
/ PROGRAMMES:
(Z) CALIBRATION OF
INSTRUMENTS:
© 2007 Center for Pharmaceutical Learning
(AA)RECALL PROCEDURES:
(BB)LABELS CONTROL:
(CC)COMPLAINTS:
(DD)CORRECTIVE ACTION
ON PREVIOUS REPORTS:
13. RECALL PROCEDURE :
EXPLAIN PROCEDURE ADOPTED FOR
RECALL OF PRODUCTS:
14. QUALITY AUDIT SYSTEM :
(BRIEF RESPONSIBILITIES)
© 2007 Center for Pharmaceutical Learning
REMARKS:

More Related Content

What's hot

BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
Ram Mohan S R
 

What's hot (20)

pharmaceutical packaging.pptx
pharmaceutical packaging.pptxpharmaceutical packaging.pptx
pharmaceutical packaging.pptx
 
Personal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. AmsavelPersonal Hygiene for pharma industry-Dr. A. Amsavel
Personal Hygiene for pharma industry-Dr. A. Amsavel
 
GMP Training
GMP TrainingGMP Training
GMP Training
 
Media fill process and validation
Media fill process and validationMedia fill process and validation
Media fill process and validation
 
cGMP Guidelines According to Schedule M
cGMP Guidelines According to Schedule McGMP Guidelines According to Schedule M
cGMP Guidelines According to Schedule M
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 
BPR review and batch release
BPR review and batch release BPR review and batch release
BPR review and batch release
 
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...Master batch record,batch production record ,Quality Audit Type and plan &Rec...
Master batch record,batch production record ,Quality Audit Type and plan &Rec...
 
Pharmaceutical documentation
Pharmaceutical documentationPharmaceutical documentation
Pharmaceutical documentation
 
container closure system
container closure systemcontainer closure system
container closure system
 
Gowning procedure for Pharma Manufacturing Area
Gowning procedure for Pharma Manufacturing AreaGowning procedure for Pharma Manufacturing Area
Gowning procedure for Pharma Manufacturing Area
 
Introduction to GMP Training by
Introduction to GMP Training byIntroduction to GMP Training by
Introduction to GMP Training by
 
GMP Introduction
GMP IntroductionGMP Introduction
GMP Introduction
 
Manufacturing operations and Control
Manufacturing operations and ControlManufacturing operations and Control
Manufacturing operations and Control
 
Handling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. AmsavelHandling of Reserve Samples Dr.A. Amsavel
Handling of Reserve Samples Dr.A. Amsavel
 
Cdsco gmp check list
Cdsco  gmp check listCdsco  gmp check list
Cdsco gmp check list
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
 
Qualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility SystemQualification of Dissolution Test Apparatus and Validation of Utility System
Qualification of Dissolution Test Apparatus and Validation of Utility System
 
Qualification of FBD.pptx
Qualification of FBD.pptxQualification of FBD.pptx
Qualification of FBD.pptx
 
Qualification of manufacturing equipment.
Qualification of manufacturing equipment.Qualification of manufacturing equipment.
Qualification of manufacturing equipment.
 

Viewers also liked

1.Manual of Food Safety Management System, fss act 2006
1.Manual of Food Safety Management System, fss act 20061.Manual of Food Safety Management System, fss act 2006
1.Manual of Food Safety Management System, fss act 2006
Ranjan Saha
 
An analysis incoming quality control of material in manufacturing company l...
An analysis incoming quality control of material in manufacturing company   l...An analysis incoming quality control of material in manufacturing company   l...
An analysis incoming quality control of material in manufacturing company l...
Steve Sapp
 
CLEANING AND SANITATION STANDARD
CLEANING AND SANITATION  STANDARDCLEANING AND SANITATION  STANDARD
CLEANING AND SANITATION STANDARD
icmseafood
 
Quality audit 112070804012
Quality audit 112070804012Quality audit 112070804012
Quality audit 112070804012
Patel Parth
 
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas AndalasGMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
Atlantic Training, LLC.
 
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENEPRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
Bean Malicse
 

Viewers also liked (20)

Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Course
 
Checklist ISO 15378
Checklist ISO 15378Checklist ISO 15378
Checklist ISO 15378
 
1.Manual of Food Safety Management System, fss act 2006
1.Manual of Food Safety Management System, fss act 20061.Manual of Food Safety Management System, fss act 2006
1.Manual of Food Safety Management System, fss act 2006
 
Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)Good Manufacturing Practices(GMP)
Good Manufacturing Practices(GMP)
 
An analysis incoming quality control of material in manufacturing company l...
An analysis incoming quality control of material in manufacturing company   l...An analysis incoming quality control of material in manufacturing company   l...
An analysis incoming quality control of material in manufacturing company l...
 
Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing Practices
 
157882189 commissioning checklist3.11.10
157882189 commissioning checklist3.11.10157882189 commissioning checklist3.11.10
157882189 commissioning checklist3.11.10
 
CLEANING AND SANITATION STANDARD
CLEANING AND SANITATION  STANDARDCLEANING AND SANITATION  STANDARD
CLEANING AND SANITATION STANDARD
 
Quality audit 112070804012
Quality audit 112070804012Quality audit 112070804012
Quality audit 112070804012
 
"Visual management & 5S " in Lean T.P.S (Workshop slides)
"Visual management &  5S " in Lean T.P.S (Workshop slides)"Visual management &  5S " in Lean T.P.S (Workshop slides)
"Visual management & 5S " in Lean T.P.S (Workshop slides)
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
 
QUALITY ASSURANCE
QUALITY ASSURANCEQUALITY ASSURANCE
QUALITY ASSURANCE
 
Risk assessment form
Risk assessment formRisk assessment form
Risk assessment form
 
FDA GMP Training - The Quality Audit
FDA GMP Training - The Quality AuditFDA GMP Training - The Quality Audit
FDA GMP Training - The Quality Audit
 
Cleanroom, Classification, Design and
Cleanroom, Classification, Design and Cleanroom, Classification, Design and
Cleanroom, Classification, Design and
 
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas AndalasGMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
GMP & Quality Assurance Training by Fakultas Farmasi Universitas Andalas
 
Hygiene & Sanitation Presentation for Hotel & Restaurants by Ravi
Hygiene & Sanitation Presentation for Hotel & Restaurants  by RaviHygiene & Sanitation Presentation for Hotel & Restaurants  by Ravi
Hygiene & Sanitation Presentation for Hotel & Restaurants by Ravi
 
Plant layout ppt by me
Plant layout ppt by mePlant layout ppt by me
Plant layout ppt by me
 
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENEPRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
PRINCIPLES OF FOOD SANITATION, SAFETY & HYGIENE
 
Sanitary Equipment Design Principles CHECKLIST & GLOSSARY American Meat Insti...
Sanitary Equipment Design Principles CHECKLIST & GLOSSARY American Meat Insti...Sanitary Equipment Design Principles CHECKLIST & GLOSSARY American Meat Insti...
Sanitary Equipment Design Principles CHECKLIST & GLOSSARY American Meat Insti...
 

Similar to Gmp checklist

US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
ReportsnReports
 

Similar to Gmp checklist (20)

ICH Q7 Guideline
ICH Q7 GuidelineICH Q7 Guideline
ICH Q7 Guideline
 
Documentation in pharmaceutical industry
Documentation  in pharmaceutical industryDocumentation  in pharmaceutical industry
Documentation in pharmaceutical industry
 
Gmp eu chapter 6
Gmp eu chapter 6Gmp eu chapter 6
Gmp eu chapter 6
 
Chương 6. Tài liệu EU GMP.pdf
Chương 6. Tài liệu EU GMP.pdfChương 6. Tài liệu EU GMP.pdf
Chương 6. Tài liệu EU GMP.pdf
 
Batch packaging record for sterile water for injection
Batch packaging record for sterile water for injection   Batch packaging record for sterile water for injection
Batch packaging record for sterile water for injection
 
Colombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirementsColombia INVIMA medical device registration document requirements
Colombia INVIMA medical device registration document requirements
 
Ich guidelines
Ich guidelinesIch guidelines
Ich guidelines
 
Code for Manufacture of Drugs (1).pdf
Code for Manufacture of Drugs (1).pdfCode for Manufacture of Drugs (1).pdf
Code for Manufacture of Drugs (1).pdf
 
Anda submission and paragraph IV certification
Anda submission and paragraph IV certificationAnda submission and paragraph IV certification
Anda submission and paragraph IV certification
 
ISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentationISO/IEC 17025:2017 Required documentation
ISO/IEC 17025:2017 Required documentation
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industry
 
The Medical devices S.R.O.32 (I)/2018
The Medical devices S.R.O.32 (I)/2018The Medical devices S.R.O.32 (I)/2018
The Medical devices S.R.O.32 (I)/2018
 
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
 
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptxGENERIC DRUG PRODUCT DEVELOPMENT.pptx
GENERIC DRUG PRODUCT DEVELOPMENT.pptx
 
DOCUMENTATION PI.pptx
DOCUMENTATION PI.pptxDOCUMENTATION PI.pptx
DOCUMENTATION PI.pptx
 
Documentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptxDocumentation in Pharmaceutical Industry.pptx
Documentation in Pharmaceutical Industry.pptx
 
Auditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production DepartmentAuditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production Department
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
 
CGMP
CGMPCGMP
CGMP
 
Drugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part VDrugs & Cosmetics Act 1940 Part V
Drugs & Cosmetics Act 1940 Part V
 

More from CCL Pharmaceuticals

عیون الحکایات جلد2
عیون الحکایات جلد2عیون الحکایات جلد2
عیون الحکایات جلد2
CCL Pharmaceuticals
 
عیون الحکایات جلد 1
عیون الحکایات جلد 1عیون الحکایات جلد 1
عیون الحکایات جلد 1
CCL Pharmaceuticals
 
Change management excellence using the five intelligences for successful or...
Change management excellence   using the five intelligences for successful or...Change management excellence   using the five intelligences for successful or...
Change management excellence using the five intelligences for successful or...
CCL Pharmaceuticals
 
Problems during granulation & compression
Problems during granulation & compressionProblems during granulation & compression
Problems during granulation & compression
CCL Pharmaceuticals
 

More from CCL Pharmaceuticals (20)

Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
 
عیون الحکایات جلد2
عیون الحکایات جلد2عیون الحکایات جلد2
عیون الحکایات جلد2
 
عیون الحکایات جلد 1
عیون الحکایات جلد 1عیون الحکایات جلد 1
عیون الحکایات جلد 1
 
Eid Melaad ul Nabi
Eid Melaad ul NabiEid Melaad ul Nabi
Eid Melaad ul Nabi
 
بے مثل بشریت
بے مثل بشریتبے مثل بشریت
بے مثل بشریت
 
Allah k nabi k abao ajdad musalman thay
Allah k nabi k abao ajdad musalman thayAllah k nabi k abao ajdad musalman thay
Allah k nabi k abao ajdad musalman thay
 
Allah jhoot k aib se paak he
Allah jhoot k aib se paak heAllah jhoot k aib se paak he
Allah jhoot k aib se paak he
 
Abhaas e-akheera
Abhaas e-akheeraAbhaas e-akheera
Abhaas e-akheera
 
Imam hussain or yazeed k wakeel
Imam hussain or yazeed k wakeelImam hussain or yazeed k wakeel
Imam hussain or yazeed k wakeel
 
Burhane sadaqatbaradnajd
Burhane sadaqatbaradnajdBurhane sadaqatbaradnajd
Burhane sadaqatbaradnajd
 
kHUTBAT-E-MAOLANA ANSARI
kHUTBAT-E-MAOLANA ANSARIkHUTBAT-E-MAOLANA ANSARI
kHUTBAT-E-MAOLANA ANSARI
 
Stress management
Stress managementStress management
Stress management
 
shia mazhab or sunni
shia mazhab or sunnishia mazhab or sunni
shia mazhab or sunni
 
Change management excellence using the five intelligences for successful or...
Change management excellence   using the five intelligences for successful or...Change management excellence   using the five intelligences for successful or...
Change management excellence using the five intelligences for successful or...
 
8 steps to change
8 steps to change8 steps to change
8 steps to change
 
Baba karmoo
Baba karmooBaba karmoo
Baba karmoo
 
Blister packing
Blister packingBlister packing
Blister packing
 
Problems during granulation & compression
Problems during granulation & compressionProblems during granulation & compression
Problems during granulation & compression
 
Quran samjein
Quran samjeinQuran samjein
Quran samjein
 
Shahkar-e-Raboobiyat
Shahkar-e-Raboobiyat Shahkar-e-Raboobiyat
Shahkar-e-Raboobiyat
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 

Gmp checklist

  • 1. © 2007 Center for Pharmaceutical Learning W.H.O. G.M.P. INSPECTION PERFORMA DATE OF INSPECTING FIRM’S REPRESENTATIVES INSPECTION OFFICERS: PRESENT DURING INSPECTION FIRM’S NAME: PHONE NO. : ADDRESS: LICENCE NO.: CATEGORIES OF DRUGS MANUFACTURED AND PRODUCTION CAPACITY: DETAILS OF EXPORT, IF UNDERTAKEN ALREADY: TECHNICAL PERSONNEL: MANUFACTURING: QUALITY CONTROL: PRODUCTS TO BE CERTIFIED: PRODUCTS LICENSED: WHETHER SITEMASTER FILE SUBMITTED IF YES, COMMENTS OF INSPECTING OFFICER ON SITE MASTER FILE.
  • 2. © 2007 Center for Pharmaceutical Learning Complaint Yes/No Remark if non complaint 1. PERSONNEL: 1.1 IS ORGANISATION CHART AVAILABLE: 1.2 ARE NO. OF PERSONNEL ADEQUATE: 1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY PERSONNEL(CHECK WITH SMF): 1.4 IS QUALIFICATION AND EXPERIENCE OF PERSONNEL COMMENSURATE WITH JOB DESCRIPTION: 1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH TECHNICAL PERSONNEL SPECIFIED IN WRITTING WITH JOB DESCRIPTION: 1.6 CHECK WHETHER THERE ARE GAPS OR UNEXPLAINED OVERLAP OF RESPONSIBILITIES OF THE CONCERNED PERSONNEL: 2. TRAINING OF PERSONNEL: 2.1 IS WRITTEN PROGRAMME FOR TRAINING AVAILABLE: 2.2 ARE ALL PERSONNEL TRAINED INITIALLY: 2.3 ARE PERIODICAL ASSESMENT RECORDS AVAILABLE 2.4 IS SPECIAL PROGRAMME AVAILABLE FOR PERSONNEL WORKING IN CLEAN AREAS AND AREAS WHERE HIGHLY ACTIVE AND TOXIC MATERIAL & HANDLED: 2.5 IS SOPs FOR TRAINING OF PERSONNEL AVAILABLE: 3. PERSONNEL HYGIENE OF PERSONNEL: 3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED PRIOR TO = AND DURING EMPLOYMENT: 3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS DICTATE: 3.3 IS SOPs FOR CLOTHING AND HYGIENE AVAILABLE:
  • 3. © 2007 Center for Pharmaceutical Learning 3.4 ARE CLEAN UNIFORMS AND HAIR COVERING CAPS USED: 3.5 CHECK NO. OF UNIFORMS PROVIDED. ARE THEY ADEQUATE: 3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED FOR VISITORS / OUTSIDE PERSONNEL ENTERING IN PRODUCTION AREAS. ARE THEY ADEQUATE: 4. PREMISES : 4.1 BRIEF DESCRIPTION OF BUILDING 4.2 IS DESIGNS AND CONSTRUCTED: 4.3 IS THE PREMISES COMPLY WITH SMF AND SITUATED IN AN ENVIRONMENT WHICH CAUSED MINIMUM RISK OF CONTAMINATION TO MATERIALS OR PRODUCTS: 4.4 IS AREA PROVIDED COMMENSURATE WITH PRODUCTION: 4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED IN THE PREMISES. IF YES, GIVE DETAILS: 4.6 ARE SOPs AVAILABLE FOR MAINTENANCE, CLEANING AND SANITATION OF BUILDINGS, PREMISES AND SURROUNDING 4.7 CHECK WHETHER THE AREA IS CLEANED AND VALIDATED BEFORE STARTING STORING /PROCESING /PACKING OPERATIONS: 4.8 IS ELECTRICAL SUPPLY, LIGHTING,TEMPERATURE,HUMIDITY,AND VENTILATION APPROPRIATE: 4.9 ARE ARRANGEMENT MADE FOR CONTROL OF ENTRY OF RODENTS& BIRD 4.10 ARE FOLLOWING AREAS PROVIDED: (A) SEPARATE REST ROOMS AND REFRESHMENT ROOMS: (B) SEPARATE CHANGING ROOMS AND TOILETS FOR MALE AND FEMALE WORKERS: (C) WORKSHOP IN A SEPARATE PLACE: (D) ANIMAL HOUSES WITH SEPARATE ENTRY AND AIR HANDLING UNIT: 5. STORAGE AREAS: 5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE
  • 4. © 2007 Center for Pharmaceutical Learning OF MATERIALS: 5.2 INDICATE AREAS FOR EACH CATEGORY AND WHETHER BARRIERS ARE PROVIDED IF NOT, EXPLAIN MODE OF SEGREGATION: RAW MATERIALS: QUARANTINE: APPROVED: REJECTED: PACKING MATERIALS: IS ACCESS TO QUARANTINE AREA RESTRICTED: 5.4 ARE REJECTED GOODS MARKED AND STORED SEPARATELY IN A SECURED AREA: 5.5 ARE RECORDS FOR ACTION TAKEN ON REJECTED GOODS AVAILABLE: 5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN CONTROLLED TEMPERATURE/ HUMIDITY: 5.7 IS RECORD OF TEMPERATURE AND HUMIDITY MAINTAINED: 5.8 ARE RECEIVING BAYS COVERED 5.9 ARE INCOMING MATERIALS CLEANED BEFORE ENTRY TO STORAGE AREA: 5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF , NOT HOW CONTAMINATION AND CROSS CONTAMINATION IS PREVENTED: 5.11 ARE SENSITIVE MATERIALS/ HORMONES,BLACTUM, ANTIBIOTICS, NARCOTICS,INFLAMMABLES, EXPLOSIVES STORED IN SECURED AREA: 5.12 ARE PRINTED/CODED PACKING MATERIALS AND CUT LABELS STORED IN SECURED AREA WITH RESTRICTED ENTRY,AND WHETHER PACKING MATERIALS LINE LABELS,CARTONS.LEAFLETS ARE IN PIGEON HOLE, ALMIRAH: 5.13 IS DISPENSING AREA PROVIDED WITH DUST
  • 5. © 2007 Center for Pharmaceutical Learning CONTROL PROVISION: 5.14 DESCRIBE THE PRIMARY PACKING MATERIALS STORAGE AREA: 6. PRODUCTION AREA: 6.1 ARE PRODUCTION AREAS FOR THE FOLLOWINGS SEPARATED AND SELF CONTAIN. DESCRIBE THE NATURE OF SEPARATION: (A) BETA- LACTUM ANTIBIOTICS: (B) HORMONES/CORTICOSTEROIDS (C) OTHER DRUGS. 6.2 WHETHER THE ACCESS TO PRODUCTION AREA RESTRICTED TO AUTHORISED PERSONNEL: 6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND FREE FROM CRACKS: 6.4 IS THE PRODUCTION AREA WELL-LIT: 6.5 HOW CROSS CONTAMINATION OF STARTING MATERIAL OR OF A PRODUCT BY ANOTHER MATERIAL OR PRODUCT IS PREVENTED: 6.6 IS THE LAY OUT OF MANUFACTURING DIVISION OF EACH CATEGORY OF DOSAGE FORM IN LOGICAL SEQUENCE. IF NOT, GIVE DETAILS WITH REFERENCE TO FLOOR PLAN: 6.7 IS WORKING SPACE ADEQUATE AND ATLEAST ONE METER PROVIDED AROUND FOR EACH EQUIPMENT: 6.8 ARE SERVICE LINES, LIGHT FITTINGS CONCEALED AND FLUSHED TO THE SURFACE OR MADE ACCESSIBLE FROM OUTSIDE. LOOK FOR PROTRUDING SURFACE AND SPECIFY: 6.9 ARE DRAINE PROVIDED WITH TRAPS TO AVOID BACK FLOW 6.10 ARE DRAINS CLEANED AND DISINFECTED PERIODICALLY. CHECK RECORDS: 6.11 IS PRODUCTION AREA PROVIDED WITH PROPER VENTILATION WITH AIRCONTROL FACILITIES (FILTRATION, TEMPERATURE AND HUMIDITY).ARE RECORDS MAINTAINED
  • 6. © 2007 Center for Pharmaceutical Learning THEREOF. 6.12 ARE LOCKERS PROVIDED FOR STORAGE OF TOOLS AND PARTS: 6.13 ARE PACKAGING AND VISUAL INSPECTION AREAS DESIGNED TO FACILITATE SEGREGATION FOR EACH WORK LINE: 6.14 ARE EQUIPMENTS: (A) LOCATED IN LOGICAL SEQUENCE (GIVE BRIEF DESCRIPTION): (B) DESIGNED, CONSTRUCTED TO SUIT THE PURPOSE: (C) PERMIT EFFECTIVE CLEANING: (D) CLEANED BETWEEN BATCH OPERATION AND RECORDED.CHECK RECORDS: (E) CALLED TO INDICATE THEIR STATUS: 6.15 ARE SERVICE LINES PAINTED TO INDICATE THE CONTENTS AND FLOW. RECORDS THE ORDER SCHEME: 6.16 ARE BALANCES AND MEASURING EQUIPMENTS CALIBRATED PERIODICALLY.CHECK RECORDS AND PERIODICITY: 6.17 ARE WEIGHING EQUIPMENTS AND MEASURING EQUIPMENTS OF APPROPRIATE RANGE AND PRECISION AVAILABLE. CHECK CAPACITY OF THE EQUIPMENT VIS-À-VIS BATCH SIZES OF PRODUCTION: 6.18 CHECK THE TYPE OF WASHING AND CLEANING EQUIPMENTS IN PRODUCTION AREA.(PARTICLE GENERATING EQUIPMENTS SHOULD NOT BE USED): 6.19 HOW DEFECTIVE EQUIPMENTS ARE SEGREGATED: 7. MATERIALS: 7.1 IS SEGREGATION IS LOTWISE AND STOCK ROTATION BY FIFO ADOPTED: 7.2 DOES PURCHASE DEPARTMENT STAFF KNOWLEDGEABLE ABOUT THE PRODUCTS AND MATERIALS: 7.3 HOW SUPPLIERS ARE SELECTED: 7.4 ARE SUPPLIERS EVALUATED AND APPROVED AND THEIR NAME INCLUDED IN SPECIFICATION:
  • 7. © 2007 Center for Pharmaceutical Learning 7.5 ARE PURCHASES MADE DIRECTLY FROM PRODUCERS: 7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND CONFORMITY WITH ORDER ON RECEIPT: 7.7 IS DAMAGE RECORDED AND REPORTED TO QUALITY CONTROL: 7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. , STATUS,EXPIRY DATE , RETEST DATE ETC.(COLLECT) SAMPLE OF INHOUSE LABELS): 7.9 IS COLOUR CODING SYSTEM USED TO INDICATE STATUS: 7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND RELEASED: 7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND DISPENSING AVAILABLE. COMPARE SOPs WITH ACTUAL PRACTICE: 7.12 IS SAMPLING AND DISPENSING DONE BY DESIGNATED PERSONS: 7.13 IS EACH DISPENSING CHECKED AND RECORDED. 7.14 IS ADEQUATE STORAGE AREA FOR FINISHED GOODS PROVIDED: 7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED PRODUCTS PROVIDED: 7.16 ARE PACKING MATERIALS CHECKED ON DELIVERY AND ASSIGNED A SPECIFIC REFERENCE NUMBER: 7.17 HOW THE WASTE MATERIALS FROM STORE,PRODUCTION, QUALITYCONTROL DISPOSED OFF: 7.18 IS THERE ACCUMULATION OF WASTE MATERIAL AT ANY PART OF THE STORAGE/ PRODUCTION/Q.C.AREA: 8. DOCUMENTATION: 8.1 ARE ALL DOCUMENTS PREPARED AND REVIEWED BY COMPETENT PERSONNEL APPROVED AND SIGNED BY AUTHORISED PERSONNEL: 8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED: 8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR EASY FOR REPRODUCTION AND EASY TO CHECK:
  • 8. © 2007 Center for Pharmaceutical Learning 8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF YES, ARE ALTERATIONS CLEAR, LEGIBLE AND INITIALLED(OVER WRITING IS NOT PERMITTED): 8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE WITH NECESSARY DETAILS: (A) TESTING PROCEDURES FOR STARTING MATERIALS, INTERMEDIATE PRODUCTS AND FINISHED PRODUCTS,PACKING MATERIALS: (B) VALIDATION OF TESTING PROCEDURE: (C) MASTER FORMULA CARD(COLLECT SPECIMEN): (D) PACKAGING INSTRUCTION (COLLECT SPECIMEN): (E) BATCH PROCESSING CARDS INCLUDING INPROCESS CONTROLS.(COLLECT SPECIMEN): (F) BATCH PACKAGING CARD (COLLECT SPECIMEN): (G) REFERENCE STANDARDS: (H) DISPOSAL RECORD OF OUTDATED PRIMARY AND PRINTED PACKING MATERIALS: (I) RELEASE RECORDS: (J) DISTRIBUTION RECORDS.(WITH WHAT LEVEL): (K) COMPARE MASTER FORMULA CARD WITH
  • 9. © 2007 Center for Pharmaceutical Learning ACTUAL PRACTICE: 8.6 ARE ALL RECORDS AND ASSOCIATED SOPs RETAINED UPTO ONE YEAR AFTER EXPIRY OF FINISHED PRODUCT: 8.7 ARE STANDARD OPERATING PROCEDURES FOR THE FOLLOWING OPERATIONS AVAILABLE: (A) RECEIPT MATERIALS: (B) ENVIRONMENTAL MONITORING: (C) INTERNAL LABELLING , QUARANTINE AND STORAGE OF MATERIALS: (D) EACH INSTRUMENT AND EQUIPMENT IN THEIR PREXIMITY: (E) EQUIPMENT ASSEMBLY AND VALIDATION: (F) SAMPLING(RAW MATERIALS AND FINISHED PRODUCTS): (G) DISPENSING (RAW MATERIALS AND PACKING MATERIALS): (H) BATCH NUMBERING SYSTEM: (I) RELEASE OR REJECTION: (J) LOG BOOK FOR EACH EQUOPMENT AND INSTRUMENT: (K) SANITATION AND CLEANING OF PREMISES AND EQUIPMENT: (L) SANITATION OF PIPES CARRYING DISTILLED/DEIONISED WATER:
  • 10. © 2007 Center for Pharmaceutical Learning (M)RECOVERY FROM REJECTED PRODUCTS: (N) DISPOSAL/REUSE OF RETURNED GOODS: (O) PEST CONTROL: (P) ANALYTICAL APPARATUS AND CALIBRATION: (Q) COMPLAINTS,RECALLS AND RETURNS: (R) COMPARE SOPs WITH ACTUAL PRACTICE: 9. PRODUCTION: 9.1 IS THERE ANY DEVIATION FROM SOPs MANUFACTURING PROCEDURES: 9.2 IS YIELD CHECKED AT EACH STAGE: 9.3 IS MORE THAN ONE PRODUCT PROCESSED IN THE SAME ROOM: 9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO INDICATE THE OPERATION IN PROGRESS: 9.5 IS ANY NON MEDICAL PRODUCT PRODUCED. SPECIFY THE DETAILS: 9.6 IS THERE PROVISION FOR INPROCESS CONTROLS IN THE PRODUCTION AREA(MUST NOT EFFECT THE QUALITY OF THE PRIODUCTS MANUFACTURED): 9.7 IS THERE PROVISION FOR DUST COLLECTION WHERE DRY MATERIALS ARE HANDLED: 9.8 IS PERIODICAL MICROBIAL MONITORING OF PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS CONDUCTED: 9.9 WAS THE AREA BEING CLEANED BEFORE STARTING EVERY BATCH: 9.10 ARE PIPES CARRYING DISTILLED/DEIONISED WATER SANITIZED ACCORDING TO PROCEDURE WHICH INDICATE LIMITS FOR MICROBIAL CONTAMINATION AND MEASURES TO BE TAKEN: 9.11 WAS ANY BATCH REPROCESSED FROM
  • 11. © 2007 Center for Pharmaceutical Learning REJECTED PRODUCTS: 9.12 WAS ANY BATCH RETURNED HAS BEEN CONVERTED FOR RESALE , RELABELLING OR BULKING: 10. PACKAGING: 10.1 IS THERE ADEQUATE SEPARATION OF PACKING LINES TO PREVENT ANY MIX-UP: 10.2 IS EACH PACKAGING LINE IDENTIFIED WITH PRODUCT NAME, BATCH NO. AND PACKAGING SIZE: 10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING SIZE ON A LINE AT ANY GIVEN TIME: 10.4 IS LINE CLEARED BEFORE EACH BATCH OPERATION,CERTIFIED AND RECORDED: 10.5 DOES PACKING QUICKLY FOLLOWS THE FILLING AND SEALING: 10.6 ARE ALL CODED PACKING MATERIALS VERIFIED BEFORE USE. 10.7 IS RECONCILATION OF PACKING MATERIALS USED VIS-À-VIS PRODUCT RECORDED: 10.8 IS ON LINE COTROL PROCEDURE DURING PACKING AVAILABLE: 11. QUALITY CONTROL: 11.1 HOW FAR THE HEAD OF QUALITY CONTROL AND PRODUCTION ARE INDEPENDENT OF EACH OTHER: 11.2 ARE ALL THE PROCEDURES OF DOCUMEBNTED: 11.3 IS SAMPLING PROCEDURE ADEQUATE: 11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW BATCH NO. , NAME,CONTAINER NO., DATE OF SAMPLING AND PERSON WHO SAMPLED: 11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER OF STARTING MATERIALS: 11.6 ARE ANALYTICAL RECORDS OF EACH BATCH OF THE RAW MATERIALS,INTERMEDIATES AND FINISHED PRODUCTS AVAILABLE WITH WORK SHEETS: 11.7 ARE PRODUCTION RECORDS REVIEWED: 11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE YEAR AFTER EXPIRY DATE AND OTHER
  • 12. © 2007 Center for Pharmaceutical Learning STARTING MATERIALS FOR A MINIMUM OF TWO YEARS: 11.9 IS PROGRAMME FOR STABILITY TESTING OF STARTING MATERIALS AND FINISHED PRODUCTS AVAILABLE: 11.10 IS STABILITY TESTING CONDUCTED PRIOR TO MARKETING AND AFTER CHANGE OF PROCESS EQUIPMENT,PACKING MATERIALS: 11.11 IS QUALITY CONTROL LAB SEPARATE FROM PRODUCTION AREA: 11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL TESTING AREAS SEPARATE FROM EACH OTHER,AND DO THEY HAVE SEPARATE AIR HANDLING FACILITIES: 11.13 IS INSTRUMENT ROOM SEPARATE: 11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE SPACE,VENTILATION AND FOR PREVENTION OF FUMES: 11.15 ARE RECORDS OF SERVICE AND CALIBRATION OF INSTRUMENT AVAILABLE: 11.16 ARE APPROPRIATE SAMPLING EQUIPMENT AVAILABLE AND STARTED SEPARATELY: 11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR TO USE: 11.18 ARE DATE OF CALIBRATION , SERVICE ,AND DATE WHEN RECALIBRATION DUE INDICATED: 11.19 ARE THE REAGENTS PREPARED ACCORDING TO WRITTEN PROCEDURES AND LABELLED APPROPRIATELY: 11.20 ARE REFERENCE STANDARDS AVAILABLE CORRESPOND TO THE MATERIALS ANALYSED: 11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY WITH COOLING) AND RECORDS ARE AVAILABLE FOR REFERENCE STANDARDS AND REFERENCE SAMPLES. CHECK THE MODE OF STORAGE OF REFERENCE STANDARDS: 11.22 ARE WORKING STANDARDS CHECKED AT REGULAR INTERVALS: 11.23 ARE THE LABELS OF REF. STANDARDS INDICATE NAME, DATE OF MFG. DATE OF EXPIRY,CONCENTRATION AND DATE OF CLOSURE IS FIRST OPENED AND STORAGE CONDITIONS:
  • 13. © 2007 Center for Pharmaceutical Learning 11.24 ARE THE LABEL OF REAGENTS PREPARED SHOW CONCENTRATION , STANDARDISATION FACTOR, SELF- LIFE,STANDARDISATION DATE ,STORAGE CONDITION AND SIGNATURE OF THE PERSON PREPARES THE REAGENTS: 11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED TO TEST SUITABILITY OF CULTURE MEDIA: 11.26 ARE STABILITY STUDIES CONDUCTED BEFORE ASSIGNING SHELF LIFE AND IS IT PERIODICALL REVIEWED, AND GIVE DETAILS: 12. SELF INSPECTION: GIVE DETAILS OF NAMES, QUALIFICATION AND BACKGROUND OF THE MEMBERS OF SELF INSPECTION TEAM: 12.1 INTERVAL PERIOD BETWEEN SELF INSPECTIONS: 12.2 DOES SELF INSPECTION REPORT CONTAINS COMMENTS ON: (A) PERSONNEL: (B) PREMISES: (C) MAINTENANCE OF BUILDING AND EQUIPMENT: (D) STORAGE: (E) EQUIPMENT: (F) PRODUCTION AND INPROCESS CONTROL: (G)QUALITY CONTROL: (H) DOCUMENTATION:
  • 14. © 2007 Center for Pharmaceutical Learning (I) SANITATION AND HYGIENE: (J) VALIDATION PROCEDURE / PROGRAMMES: (K) CALIBRATION OF INSTRUMENTS: (L) RECALL PROCEDURES: (M)LABELS CONTROL: (N) COMPLAINTS: (O)CORRECTIVE ACTION ON PREVIOUS REPORTS: 13 RECALL PROCEDURE : EXPLAIN PROCEDURE ADOPTED FOR RECALL OF PRODUCTS: 14 QUALITY AUDIT SYSTEM : (BRIEF RESPONSIBILITIES REMARKS: 1.1 IS ORGANISATION CHART AVAILABLE: 1.2 ARE NO. OF PERSONNEL ADEQUATE: 1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY PERSONNEL(CHECK WITH SMF): 1.4 IS QUALIFICATION AND EXPERIENCE OF PERSONNEL COMMENSURATE WITH JOB DESCRIPTION: 1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH
  • 15. © 2007 Center for Pharmaceutical Learning TECHNICAL PERSONNEL SPECIFIED IN WRITTING WITH JOB DESCRIPTION: 1.6 CHECK WHETHER THERE ARE GAPS OR UNEXPLAINED OVERLAP OF RESPONSIBILITIES OF THE CONCERNED PERSONNEL: 2. TRAINING OF PERSONNEL: 2.1 IS WRITTEN PROGRAMME FOR TRAINING AVAILABLE: 2.2 ARE ALL PERSONNEL TRAINED INITIALLY: 2.3 ARE PERIODICAL ASSESMENT RECORDS AVAILABLE 2.4 IS SPECIAL PROGRAMME AVAILABLE FOR PERSONNEL WORKING IN CLEAN AREAS AND AREAS WHERE HIGHLY ACTIVE AND TOXIC MATERIAL & HANDLED: 2.5 IS SOPs FOR TRAINING OF PERSONNEL AVAILABLE: 3. PERSONNEL HYGIENE OF PERSONNEL: 3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED PRIOR TO = AND DURING EMPLOYMENT: 3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS DICTATE: 3.3 IS SOPs FOR CLOTHING AND HYGIENE AVAILABLE: 3.4 ARE CLEAN UNIFORMS AND HAIR COVERING CAPS USED: 3.5 CHECK NO. OF UNIFORMS
  • 16. © 2007 Center for Pharmaceutical Learning PROVIDED. ARE THEY ADEQUATE: 3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED FOR VISITORS / OUTSIDE PERSONNEL ENTERING IN PRODUCTION AREAS. ARE THEY ADEQUATE: 6. PREMISES : 4.1 BRIEF DESCRIPTION OF BUILDING 4.2 IS DESIGNS AND CONSTRUCTED: 4.3 IS THE PREMISES COMPLY WITH SMF AND SITUATED IN AN ENVIRONMENT WHICH CAUSED MINIMUM RISK OF CONTAMINATION TO MATERIALS OR PRODUCTS: 4.4 IS AREA PROVIDED COMMENSURATE WITH PRODUCTION: 4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED IN THE PREMISES. IF YES, GIVE DETAILS: 4.6 ARE SOPs AVAILABLE FOR MAINTENANCE, CLEANING AND SANITATION OF BUILDINGS, PREMISES AND SURROUNDING 4.7 CHECK WHETHER THE AREA IS CLEANED AND VALIDATED BEFORE STARTING STORING /PROCESING /PACKING OPERATIONS: 4.8 IS ELECTRICAL SUPPLY, LIGHTING,TEMPERATURE,HUMIDITY,AND VENTILATION APPROPRIATE: 4.9 ARE ARRANGEMENT MADE FOR CONTROL OF ENTRY OF RODENTS& BIRD 4.10 ARE FOLLOWING AREAS PROVIDED: (A) SEPARATE REST ROOMS AND REFRESHMENT ROOMS: (B) SEPARATE CHANGING ROOMS AND TOILETS FOR MALE AND
  • 17. © 2007 Center for Pharmaceutical Learning FEMALE WORKERS: (C) WORKSHOP IN A SEPARATE PLACE: (D) ANIMAL HOUSES WITH SEPARATE ENTRY AND AIR HANDLING UNIT: 7. STORAGE AREAS: 5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE OF MATERIALS: 5.2 INDICATE AREAS FOR EACH CATEGORY AND WHETHER BARRIERS ARE PROVIDED IF NOT, EXPLAIN MODE OF SEGREGATION: RAW MATERIALS: QUARANTINE: APPROVED: REJECTED: PACKING MATERIALS: IS ACCESS TO QUARANTINE AREA RESTRICTED: 5.4 ARE REJECTED GOODS MARKED AND STORED SEPARATELY IN A SECURED AREA: 5.5 ARE RECORDS FOR ACTION TAKEN ON REJECTED GOODS AVAILABLE: 5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN
  • 18. © 2007 Center for Pharmaceutical Learning CONTROLLED TEMPERATURE/ HUMIDITY: 5.7 IS RECORD OF TEMPERATURE AND HUMIDITY MAINTAINED: 5.8 ARE RECEIVING BAYS COVERED 5.9 ARE INCOMING MATERIALS CLEANED BEFORE ENTRY TO STORAGE AREA: 5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF , NOT HOW CONTAMINATION AND CROSS CONTAMINATION IS PREVENTED: 5.11 ARE SENSITIVE MATERIALS/ HORMONES,BLACTUM, ANTIBIOTICS, NARCOTICS,INFLAMMABLES, EXPLOSIVES STORED IN SECURED AREA: 5.12 ARE PRINTED/CODED PACKING MATERIALS AND CUT LABELS STORED IN SECURED AREA WITH RESTRICTED ENTRY,AND WHETHER PACKING MATERIALS LINE LABELS,CARTONS.LEAFLETS ARE IN PIGEON HOLE, ALMIRAH: 5.13 IS DISPENSING AREA PROVIDED WITH DUST CONTROL PROVISION: 5.14 DESCRIBE THE PRIMARY PACKING MATERIALS STORAGE AREA: 7. PRODUCTION AREA:
  • 19. © 2007 Center for Pharmaceutical Learning 6.1 ARE PRODUCTION AREAS FOR THE FOLLOWINGS SEPARATED AND SELF CONTAIN. DESCRIBE THE NATURE OF SEPARATION: (D) BETA- LACTUM ANTIBIOTICS: (E) HORMONES/CORTICOSTEROIDS (F) OTHER DRUGS. 6.2 WHETHER THE ACCESS TO PRODUCTION AREA RESTRICTED TO AUTHORISED PERSONNEL: 6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND FREE FROM CRACKS: 6.4 IS THE PRODUCTION AREA WELL-LIT: 6.5 HOW CROSS CONTAMINATION OF STARTING MATERIAL OR OF A PRODUCT BY ANOTHER MATERIAL OR PRODUCT IS PREVENTED: 6.6 IS THE LAY OUT OF MANUFACTURING DIVISION OF EACH CATEGORY OF DOSAGE FORM IN LOGICAL SEQUENCE. IF NOT, GIVE DETAILS WITH REFERENCE TO FLOOR PLAN: 6.7 IS WORKING SPACE ADEQUATE AND ATLEAST ONE METER PROVIDED AROUND FOR EACH EQUIPMENT: 6.8 ARE SERVICE LINES, LIGHT FITTINGS CONCEALED AND FLUSHED TO THE SURFACE OR MADE ACCESSIBLE FROM OUTSIDE. LOOK FOR PROTRUDING SURFACE AND SPECIFY: 6.9 ARE DRAINE PROVIDED WITH
  • 20. © 2007 Center for Pharmaceutical Learning TRAPS TO AVOID BACK FLOW 6.10 ARE DRAINS CLEANED AND DISINFECTED PERIODICALLY. CHECK RECORDS: 6.11 IS PRODUCTION AREA PROVIDED WITH PROPER VENTILATION WITH AIRCONTROL FACILITIES (FILTRATION, TEMPERATURE AND HUMIDITY).ARE RECORDS MAINTAINED THEREOF. 6.12 ARE LOCKERS PROVIDED FOR STORAGE OF TOOLS AND PARTS: 6.13 ARE PACKAGING AND VISUAL INSPECTION AREAS DESIGNED TO FACILITATE SEGREGATION FOR EACH WORK LINE: 6.14 ARE EQUIPMENTS: (F) LOCATED IN LOGICAL SEQUENCE (GIVE BRIEF DESCRIPTION): (G) DESIGNED, CONSTRUCTED TO SUIT THE PURPOSE: (H) PERMIT EFFECTIVE CLEANING: (I) CLEANED BETWEEN BATCH OPERATION AND RECORDED.CHECK RECORDS: (J) CALLED TO INDICATE THEIR STATUS: 6.15 ARE SERVICE LINES PAINTED TO INDICATE THE CONTENTS AND FLOW. RECORDS THE ORDER SCHEME: 6.16 ARE BALANCES AND
  • 21. © 2007 Center for Pharmaceutical Learning MEASURING EQUIPMENTS CALIBRATED PERIODICALLY.CHECK RECORDS AND PERIODICITY: 6.17 ARE WEIGHING EQUIPMENTS AND MEASURING EQUIPMENTS OF APPROPRIATE RANGE AND PRECISION AVAILABLE. CHECK CAPACITY OF THE EQUIPMENT VIS-À-VIS BATCH SIZES OF PRODUCTION: 6.18 CHECK THE TYPE OF WASHING AND CLEANING EQUIPMENTS IN PRODUCTION AREA.(PARTICLE GENERATING EQUIPMENTS SHOULD NOT BE USED): 6.19 HOW DEFECTIVE EQUIPMENTS ARE SEGREGATED: 8. MATERIALS: 7.1 IS SEGREGATION IS LOTWISE AND STOCK ROTATION BY FIFO ADOPTED: 7.2 DOES PURCHASE DEPARTMENT STAFF KNOWLEDGEABLE ABOUT THE PRODUCTS AND MATERIALS: 7.3 HOW SUPPLIERS ARE SELECTED: 7.4 ARE SUPPLIERS EVALUATED AND APPROVED AND THEIR NAME INCLUDED IN SPECIFICATION: 7.5 ARE PURCHASES MADE DIRECTLY FROM PRODUCERS: 7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND CONFORMITY WITH ORDER ON RECEIPT:
  • 22. © 2007 Center for Pharmaceutical Learning 7.7 IS DAMAGE RECORDED AND REPORTED TO QUALITY CONTROL: 7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. , STATUS,EXPIRY DATE , RETEST DATE ETC.(COLLECT) SAMPLE OF INHOUSE LABELS): 7.9 IS COLOUR CODING SYSTEM USED TO INDICATE STATUS: 7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND RELEASED: 7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND DISPENSING AVAILABLE. COMPARE SOPs WITH ACTUAL PRACTICE: 7.12 IS SAMPLING AND DISPENSING DONE BY DESIGNATED PERSONS: 7.13 IS EACH DISPENSING CHECKED AND RECORDED. 7.14 IS ADEQUATE STORAGE AREA FOR FINISHED GOODS PROVIDED: 7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED PRODUCTS PROVIDED: 7.16 ARE PACKING MATERIALS CHECKED ON DELIVERY AND ASSIGNED A SPECIFIC REFERENCE NUMBER: 7.17 HOW THE WASTE MATERIALS FROM STORE,PRODUCTION, QUALITYCONTROL DISPOSED OFF: 7.18 IS THERE ACCUMULATION OF WASTE MATERIAL AT ANY PART OF THE STORAGE/ PRODUCTION/Q.C.AREA:
  • 23. © 2007 Center for Pharmaceutical Learning 9. DOCUMENTATION: 8.1 ARE ALL DOCUMENTS PREPARED AND REVIEWED BY COMPETENT PERSONNEL APPROVED AND SIGNED BY AUTHORISED PERSONNEL: 8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED: 8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR EASY FOR REPRODUCTION AND EASY TO CHECK: 8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF YES, ARE ALTERATIONS CLEAR, LEGIBLE AND INITIALLED(OVER WRITING IS NOT PERMITTED): 8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE WITH NECESSARY DETAILS: (L) TESTING PROCEDURES FOR STARTING MATERIALS, INTERMEDIATE PRODUCTS AND FINISHED PRODUCTS,PACKING MATERIALS: (M)VALIDATION OF TESTING PROCEDURE: (N) MASTER FORMULA CARD(COLLECT SPECIMEN): (O) PACKAGING INSTRUCTION (COLLECT SPECIMEN):
  • 24. © 2007 Center for Pharmaceutical Learning (P) BATCH PROCESSING CARDS INCLUDING INPROCESS CONTROLS.(COLLECT SPECIMEN): (Q) BATCH PACKAGING CARD (COLLECT SPECIMEN): (R) REFERENCE STANDARDS: (S) DISPOSAL RECORD OF OUTDATED PRIMARY AND PRINTED PACKING MATERIALS: (T) RELEASE RECORDS: (U) DISTRIBUTION RECORDS.(WITH WHAT LEVEL): (V) COMPARE MASTER FORMULA CARD WITH ACTUAL PRACTICE: 8.6 ARE ALL RECORDS AND ASSOCIATED SOPs RETAINED UPTO ONE YEAR AFTER EXPIRY OF FINISHED PRODUCT: 8.7 ARE STANDARD OPERATING PROCEDURES FOR THE FOLLOWING OPERATIONS AVAILABLE: (S) RECEIPT MATERIALS: (T) ENVIRONMENTAL MONITORING:
  • 25. © 2007 Center for Pharmaceutical Learning (U) INTERNAL LABELLING , QUARANTINE AND STORAGE OF MATERIALS: (V) EACH INSTRUMENT AND EQUIPMENT IN THEIR PREXIMITY: (W)EQUIPMENT ASSEMBLY AND VALIDATION: (X) SAMPLING(RAW MATERIALS AND FINISHED PRODUCTS): (Y) DISPENSING (RAW MATERIALS AND PACKING MATERIALS): (Z) BATCH NUMBERING SYSTEM: (AA)RELEASE OR REJECTION: (BB)LOG BOOK FOR EACH EQUOPMENT AND INSTRUMENT: (CC)SANITATION AND CLEANING OF PREMISES AND EQUIPMENT: (DD)SANITATION OF PIPES CARRYING DISTILLED/DEIONISED WATER:
  • 26. © 2007 Center for Pharmaceutical Learning (EE)RECOVERY FROM REJECTED PRODUCTS: (FF)DISPOSAL/REUSE OF RETURNED GOODS: (GG)PEST CONTROL: (HH)ANALYTICAL APPARATUS AND CALIBRATION: (II) COMPLAINTS,RECALLS AND RETURNS: (JJ) COMPARE SOPs WITH ACTUAL PRACTICE: 11. PRODUCTION: 9.1 IS THERE ANY DEVIATION FROM SOPs MANUFACTURING PROCEDURES: 9.2 IS YIELD CHECKED AT EACH STAGE: 9.3 IS MORE THAN ONE PRODUCT PROCESSED IN THE SAME ROOM: 9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO INDICATE THE OPERATION IN PROGRESS: 9.5 IS ANY NON MEDICAL PRODUCT PRODUCED. SPECIFY THE DETAILS: 9.6 IS THERE PROVISION FOR INPROCESS CONTROLS IN THE PRODUCTION AREA(MUST NOT EFFECT THE QUALITY OF THE PRIODUCTS MANUFACTURED): 9.7 IS THERE PROVISION FOR
  • 27. © 2007 Center for Pharmaceutical Learning DUST COLLECTION WHERE DRY MATERIALS ARE HANDLED: 9.8 IS PERIODICAL MICROBIAL MONITORING OF PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS CONDUCTED: 9.9 WAS THE AREA BEING CLEANED BEFORE STARTING EVERY BATCH: 9.10 ARE PIPES CARRYING DISTILLED/DEIONISED WATER SANITIZED ACCORDING TO PROCEDURE WHICH INDICATE LIMITS FOR MICROBIAL CONTAMINATION AND MEASURES TO BE TAKEN: 9.11 WAS ANY BATCH REPROCESSED FROM REJECTED PRODUCTS: 9.12 WAS ANY BATCH RETURNED HAS BEEN CONVERTED FOR RESALE , RELABELLING OR BULKING: 12. PACKAGING: 10.1 IS THERE ADEQUATE SEPARATION OF PACKING LINES TO PREVENT ANY MIX- UP: 10.2 IS EACH PACKAGING LINE IDENTIFIED WITH PRODUCT NAME, BATCH NO. AND PACKAGING SIZE: 10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING SIZE ON A LINE AT ANY GIVEN TIME: 10.4 IS LINE CLEARED BEFORE EACH BATCH OPERATION,CERTIFIED AND RECORDED: 10.5 DOES PACKING QUICKLY
  • 28. © 2007 Center for Pharmaceutical Learning FOLLOWS THE FILLING AND SEALING: 10.6 ARE ALL CODED PACKING MATERIALS VERIFIED BEFORE USE. 10.7 IS RECONCILATION OF PACKING MATERIALS USED VIS-À-VIS PRODUCT RECORDED: 10.8 IS ON LINE COTROL PROCEDURE DURING PACKING AVAILABLE: 13. QUALITY CONTROL: 11.1 HOW FAR THE HEAD OF QUALITY CONTROL AND PRODUCTION ARE INDEPENDENT OF EACH OTHER: 11.2 ARE ALL THE PROCEDURES OF DOCUMEBNTED: 11.3 IS SAMPLING PROCEDURE ADEQUATE: 11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW BATCH NO. , NAME,CONTAINER NO., DATE OF SAMPLING AND PERSON WHO SAMPLED: 11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER OF STARTING MATERIALS: 11.6 ARE ANALYTICAL RECORDS OF EACH BATCH OF THE RAW MATERIALS,INTERMEDIATES AND FINISHED PRODUCTS AVAILABLE WITH WORK SHEETS: 11.7 ARE PRODUCTION RECORDS REVIEWED: 11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE YEAR AFTER EXPIRY DATE AND OTHER
  • 29. © 2007 Center for Pharmaceutical Learning STARTING MATERIALS FOR A MINIMUM OF TWO YEARS: 11.9 IS PROGRAMME FOR STABILITY TESTING OF STARTING MATERIALS AND FINISHED PRODUCTS AVAILABLE: 11.10 IS STABILITY TESTING CONDUCTED PRIOR TO MARKETING AND AFTER CHANGE OF PROCESS EQUIPMENT,PACKING MATERIALS: 11.11 IS QUALITY CONTROL LAB SEPARATE FROM PRODUCTION AREA: 11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL TESTING AREAS SEPARATE FROM EACH OTHER,AND DO THEY HAVE SEPARATE AIR HANDLING FACILITIES: 11.13 IS INSTRUMENT ROOM SEPARATE: 11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE SPACE,VENTILATION AND FOR PREVENTION OF FUMES: 11.15 ARE RECORDS OF SERVICE AND CALIBRATION OF INSTRUMENT AVAILABLE: 11.16 ARE APPROPRIATE SAMPLING EQUIPMENT AVAILABLE AND STARTED SEPARATELY: 11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR TO USE: 11.18 ARE DATE OF CALIBRATION , SERVICE ,AND DATE WHEN RECALIBRATION DUE INDICATED: 11.19 ARE THE REAGENTS PREPARED ACCORDING TO WRITTEN PROCEDURES AND LABELLED APPROPRIATELY:
  • 30. © 2007 Center for Pharmaceutical Learning 11.20 ARE REFERENCE STANDARDS AVAILABLE CORRESPOND TO THE MATERIALS ANALYSED: 11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY WITH COOLING) AND RECORDS ARE AVAILABLE FOR REFERENCE STANDARDS AND REFERENCE SAMPLES. CHECK THE MODE OF STORAGE OF REFERENCE STANDARDS: 11.22 ARE WORKING STANDARDS CHECKED AT REGULAR INTERVALS: 11.23 ARE THE LABELS OF REF. STANDARDS INDICATE NAME, DATE OF MFG. DATE OF EXPIRY,CONCENTRATION AND DATE OF CLOSURE IS FIRST OPENED AND STORAGE CONDITIONS: 11.24 ARE THE LABEL OF REAGENTS PREPARED SHOW CONCENTRATION , STANDARDISATION FACTOR, SELF- LIFE,STANDARDISATION DATE ,STORAGE CONDITION AND SIGNATURE OF THE PERSON PREPARES THE REAGENTS: 11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED TO TEST SUITABILITY OF CULTURE MEDIA: 11.26 ARE STABILITY STUDIES CONDUCTED BEFORE ASSIGNING SHELF LIFE AND IS IT PERIODICALL REVIEWED, AND GIVE DETAILS: 14. SELF INSPECTION:
  • 31. © 2007 Center for Pharmaceutical Learning GIVE DETAILS OF NAMES, QUALIFICATION AND BACKGROUND OF THE MEMBERS OF SELF INSPECTION TEAM: 12.1 INTERVAL PERIOD BETWEEN SELF INSPECTIONS: 12.2 DOES SELF INSPECTION REPORT CONTAINS COMMENTS ON: (P) PERSONNEL: (Q) PREMISES: (R) MAINTENANCE OF BUILDING AND EQUIPMENT: (S) STORAGE: (T) EQUIPMENT: (U) PRODUCTION AND INPROCESS CONTROL: (V) QUALITY CONTROL: (W)DOCUMENTATION: (X) SANITATION AND HYGIENE: (Y) VALIDATION PROCEDURE / PROGRAMMES: (Z) CALIBRATION OF INSTRUMENTS:
  • 32. © 2007 Center for Pharmaceutical Learning (AA)RECALL PROCEDURES: (BB)LABELS CONTROL: (CC)COMPLAINTS: (DD)CORRECTIVE ACTION ON PREVIOUS REPORTS: 13. RECALL PROCEDURE : EXPLAIN PROCEDURE ADOPTED FOR RECALL OF PRODUCTS: 14. QUALITY AUDIT SYSTEM : (BRIEF RESPONSIBILITIES)
  • 33. © 2007 Center for Pharmaceutical Learning REMARKS: